Fue Vang

1.1k total citations
10 papers, 780 citations indexed

About

Fue Vang is a scholar working on Infectious Diseases, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Fue Vang has authored 10 papers receiving a total of 780 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Epidemiology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Fue Vang's work include Viral gastroenteritis research and epidemiology (4 papers), Respiratory viral infections research (4 papers) and Animal Disease Management and Epidemiology (4 papers). Fue Vang is often cited by papers focused on Viral gastroenteritis research and epidemiology (4 papers), Respiratory viral infections research (4 papers) and Animal Disease Management and Epidemiology (4 papers). Fue Vang collaborates with scholars based in United States, Australia and Singapore. Fue Vang's co-authors include James E. Gern, Tressa Pappas, Michael D. Evans, Robert F. Lemanske, Wai-Ming Lee, Daniel J. Jackson, Ronald E. Gangnon, Andrew C. Martin, D. Cox and Ingrid A. Laing and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Journal of Virology and Journal of Allergy and Clinical Immunology.

In The Last Decade

Fue Vang

10 papers receiving 775 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fue Vang United States 6 492 379 258 175 168 10 780
S.‐K. Khoo Australia 10 317 0.6× 354 0.9× 264 1.0× 157 0.9× 130 0.8× 14 637
Luke Heil United States 5 512 1.0× 172 0.5× 215 0.8× 77 0.4× 132 0.8× 5 599
Wendy Fonseca United States 16 244 0.5× 124 0.3× 163 0.6× 212 1.2× 74 0.4× 29 627
Alberto Zampiero Italy 14 404 0.8× 31 0.1× 133 0.5× 84 0.5× 25 0.1× 23 638
Valia Kehagia United Kingdom 6 120 0.2× 297 0.8× 297 1.2× 171 1.0× 104 0.6× 6 609
Ulrika Holmlund Sweden 14 207 0.4× 78 0.2× 135 0.5× 348 2.0× 40 0.2× 21 619
Anita Kondrashova Finland 11 141 0.3× 89 0.2× 15 0.1× 122 0.7× 29 0.2× 16 745
Anna Karin Bernhardsson Sweden 3 153 0.3× 41 0.1× 114 0.4× 193 1.1× 39 0.2× 3 554
Elza Rencis Bryan United States 9 292 0.6× 46 0.1× 93 0.4× 24 0.1× 40 0.2× 11 429
Spyridon Megremis Greece 11 162 0.3× 75 0.2× 116 0.4× 29 0.2× 42 0.3× 25 340

Countries citing papers authored by Fue Vang

Since Specialization
Citations

This map shows the geographic impact of Fue Vang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fue Vang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fue Vang more than expected).

Fields of papers citing papers by Fue Vang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fue Vang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fue Vang. The network helps show where Fue Vang may publish in the future.

Co-authorship network of co-authors of Fue Vang

This figure shows the co-authorship network connecting the top 25 collaborators of Fue Vang. A scholar is included among the top collaborators of Fue Vang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fue Vang. Fue Vang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Tsuji, Isamu, Fue Vang, Jill A. Livengood, et al.. (2022). Somatic Hypermutation and Framework Mutations of Variable Region Contribute to Anti-Zika Virus-Specific Monoclonal Antibody Binding and Function. Journal of Virology. 96(11). e0007122–e0007122. 5 indexed citations
2.
3.
Tambyah, Paul Anantharajah, Jolene Oon, Shi-Hsia Hwa, et al.. (2019). An inactivated enterovirus 71 vaccine is safe and immunogenic in healthy adults: A phase I, double blind, randomized, placebo-controlled, study of two dosages. Vaccine. 37(31). 4344–4353. 14 indexed citations
4.
Lee, Wai-Ming, Rose F. Vrtis, Tressa Pappas, et al.. (2014). Molecular Identification and Quantification of Human Rhinoviruses in Respiratory Samples. Methods in molecular biology. 1221. 25–38. 5 indexed citations
5.
Bochkov, Yury A., Kristine A. Grindle, Fue Vang, Michael D. Evans, & James E. Gern. (2014). Improved Molecular Typing Assay for Rhinovirus Species A, B, and C. Journal of Clinical Microbiology. 52(7). 2461–2471. 62 indexed citations
6.
Bashir, Hiba, Yury A. Bochkov, Fue Vang, et al.. (2013). Differential Effects of HRV Species On Cold and Asthma Symptoms. Journal of Allergy and Clinical Immunology. 131(2). AB232–AB232. 1 indexed citations
7.
Lee, Wai-Ming, Robert F. Lemanske, Michael D. Evans, et al.. (2012). Human Rhinovirus Species and Season of Infection Determine Illness Severity. American Journal of Respiratory and Critical Care Medicine. 186(9). 886–891. 240 indexed citations
8.
Bizzintino, J., Ingrid A. Laing, Fue Vang, et al.. (2010). Association between human rhinovirus C and severity of acute asthma in children. European Respiratory Journal. 37(5). 1037–1042. 285 indexed citations
9.
Kim, Woo Kyung, Wai-Ming Lee, Fue Vang, et al.. (2010). Weekly monitoring of children with asthma for infections and illness during common cold seasons. Journal of Allergy and Clinical Immunology. 125(5). 1001–1006.e1. 149 indexed citations
10.
Pak, Jeong W., et al.. (2005). MtDNA point mutations are associated with deletion mutations in aged rat. Experimental Gerontology. 40(3). 209–218. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S.‐K. Khoo Breakdown of academic impact, for papers by Luke Heil Breakdown of academic impact, for papers by Wendy Fonseca Breakdown of academic impact, for papers by Alberto Zampiero Breakdown of academic impact, for papers by Valia Kehagia Breakdown of academic impact, for papers by Ulrika Holmlund Breakdown of academic impact, for papers by Anita Kondrashova Breakdown of academic impact, for papers by Anna Karin Bernhardsson Breakdown of academic impact, for papers by Elza Rencis Bryan Breakdown of academic impact, for papers by Spyridon Megremis
Rankless by CCL
2026